FrancophonIA/ELRC3.0 huggingface dataset:
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 75 IU (150 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 75 IU (150 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: Fertavid 200 IU/0.5 mL solution for injection
Croatian: Fertavid 200 IU/0,5 ml otopina za injekciju
English: Fertavid 75 IU/0.5 mL injection follitropin beta
Croatian: Fertavid 75 IU/0,5 ml otopina za injekciju folitropin beta
English: You should use sterile disposable syringes and needles for the administration of Fertavid.
Croatian: Za primjenu lijeka Fertavid morate koristiti sterilne štrcaljke i igle za jednokratnu uporabu.
English: One vial contains 7,5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 7,5 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 200 IU (400 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 200 IU (400 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: Fertavid 150 IU/0.18 mL injection follitropin beta
Croatian: Fertavid 150 IU/0,18 ml injekcija folitropin beta s.c.
English: Step 3 - Preparing the area
Croatian: Korak 3 - Priprema mjesta injiciranja
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 150 IU (300 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 150 IU (300 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: One vial contains 75 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 75 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 150 IU/ml.
English: Fertavid 300 IU/0.36 mL solution for injection follitropin beta
Croatian: Fertavid 300 IU/0,36 ml otopina za injekciju folitropin beta
English: VIAL TEXT Fertavid 200 IU/0.5 mL
Croatian: TEKST NA BOČICI Fertavid 200 IU/0,5 ml
English: Fertavid 150 IU/0.5 mL solution for injection
Croatian: Fertavid 150 IU/0,5 ml otopina za injekciju
English: Fertavid 50 IU/0.5 mL solution for injection EU/1/09/510/001
Croatian: Fertavid 50 IU/0,5 ml otopina za injekciju EU/1/09/510/001
English: Fertavid 150 IU/0.5 mL solution for injection EU/1/09/510/010
Croatian: Fertavid 150 IU/0,5 ml otopina za injekciju EU/1/09/510/010
English: OUTER CARTON TEXT Fertavid 150 IU/0.5 mL 1, 5 or 10 vials
Croatian: TEKST NA KUTIJI - Fertavid 150 IU/0,5 ml 1, 5 ili 10 bočica
English: Ovarian torsion has been reported after treatment with gonadotropins, including follitropin beta.
Croatian: Nakon liječenja gonadotropinima, uključujući Fertavid, prijavljena je torzija jajnika.
English: Fertavid 900 IU/1.08 mL solution for injection follitropin beta
Croatian: Fertavid 900 IU/1,08 ml otopina za injekciju folitropin beta
English: Ovarian hyperstimulation syndrome (OHSS)
Croatian: Sindrom hiperstimulacije jajnika (engl.
English: Fertavid 50 IU/0.5 mL solution for injection
Croatian: Fertavid 50 IU/0,5 ml otopina za injekciju
English: Fertavid 100 IU/0.5 mL solution for injection
Croatian: Fertavid 100 IU/0,5 ml otopina za injekciju
English: OUTER CARTON TEXT Fertavid 100 IU/0.5 mL 1, 5 or 10 vials
Croatian: TEKST NA KUTIJI - Fertavid 100 IU/0,5 ml 1, 5 ili 10 bočica
English: Multiple Pregnancy
Croatian: Višeplodna trudnoća
English: VIAL TEXT Fertavid 150 IU/0.5 mL
Croatian: TEKST NA BOČICI Fertavid 150 IU/0,5 ml
English: Fertavid 200 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 200 IU in 0.5 mL aqueous solution per vial.
Croatian: Fertavid 200 IU/0,5 ml otopina za injekciju: Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 200 IU u 0,5 ml vodene otopine po bočici.
English: Fertavid 150 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 150 IU in 0.5 mL aqueous solution per vial.
Croatian: Fertavid 150 IU/0,5 ml otopina za injekciju: Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 150 IUu 0,5 ml vodene otopine po bočici.
English: Fertavid 200 IU/0.5 mL injection follitropin beta
Croatian: Fertavid 200 IU/0,5 ml otopina za injekciju folitropin beta
English: One vial contains 150 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 150 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 300 IU/ml.
English: OUTER CARTON TEXT Fertavid 50 IU/0.5 mL 1, 5 or 10 vials
Croatian: TEKST NA KUTIJI - Fertavid 50 IU/0,5 ml 1, 5 ili 10 bočica
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 100 IU (200 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 100 IU (200 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 50 IU (100 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Croatian: 1 bočica sadrži 0,5 ml folitropina beta, što odgovara: 50 IU (100 IU/ml) aktivnosti rekombinantnog folikulostimulirajućeg hormona (FSH).
English: Fertavid 150 IU/0.5 mL injection follitropin beta
Croatian: Fertavid 150 IU/0,5 ml otopina za injekciju folitropin beta
English: Fertavid 50 IU/0.5 mL injection follitropin beta
Croatian: Fertavid 50 IU/0,5 ml otopina za injekciju folitropin beta
English: Fertavid 100 IU/0.5 mL injection follitropin beta
Croatian: Fertavid 100 IU/0,5 ml otopina za injekciju folitropin beta
English: One vial contains 5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 5 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: Fertavid 50 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 50 IU in 0.5 mL aqueous solution per vial.
Croatian: Fertavid 50 IU/0,5 ml otopina za injekciju : Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 50 IU u 0,5 ml vodene otopine po bočici.
English: One vial contains 50 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 50 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 100 IU/ml.
English: Fertavid 100 IU/0.5 mL solution for injection: Each vial contains the active substance follitropin beta, a hormone known as follicle-stimulating hormone (FSH), in a strength of 100 IU in 0.5 mL aqueous solution per vial.
Croatian: Fertavid 100 IU/0,5 ml otopina za injekciju: Jedna bočica sadrži djelatnu tvar folitropin beta, hormon poznat kao folikulostimulirajući hormon (FSH) u koncentraciji od 100 IU u 0,5 ml vodene otopine po bočici.
English: Step 6 - Injecting the solution
Croatian: Korak 6 - Injiciranje otopine
English: Keep the vial in the outer carton.
Croatian: Uložak čuvati u vanjskom pakiranju.
English: One vial contains 200 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 200 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 400 IU/ml.
English: Fertavid 600 IU/0.72 mL solution for injection follitropin beta
Croatian: Fertavid 600 IU/0,72 ml otopina za injekciju folitropin beta
English: One vial contains 20 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 20 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: One vial contains 15 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 15 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: Mean no. of oocytes retrieved Mean total dose (no. of 75 IU ampoules) Mean duration of FSH stimulation (days)
Croatian: Prosječna ukupna doza (broj ampula od 75 IU)
English: One vial contains 10 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Croatian: Jedna bočica sadrži 10 mikrograma proteina (čija specifična in vivo biološka aktivnost odgovara približno 10 000 IU FSH/mg proteina).
English: Fertavid 150 IU/0.18 mL solution for injection follitropin beta
Croatian: Fertavid 150 IU/0,18 ml otopina za injekciju folitropin beta
English: One vial contains 100 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Croatian: Jedna bočica sadrži 100 IU rekombinantnog folikulostimulirajućeg hormona (FSH) u 0,5 ml vodene otopine, što odgovara koncentraciji od 200 IU/ml.
English: • if you are awaiting a liver transplant;
Croatian: • ako čekate na transplantaciju jetre;
English: Patients should be instructed not to take a double dose.
Croatian: Pacijentima treba savjetovati da ne uzimaju dvostruku dozu.
English: Distribution Ledipasvir is > 99.8% bound to human plasma proteins.
Croatian: Ledipasvir je > 99,8 % vezan za proteine ljudske plazme.
English: * Patients lost to follow-up or who withdrew consent excluded.
Croatian: *Pacijenti izgubljeni iz praćenja ili koji su povukli pristanak bili su isključeni.
English: Patient population*
Croatian: Populacija pacijenata*
English: The recommended dose is one tablet once a day.
Croatian: Preporučena doza Preporučena doza je jedna tableta jedanput na dan.
English: If this applies to you, do not take Harvoni and tell your doctor immediately.
Croatian: Ako se ovo odnosi na Vas, nemojte uzimati Harvoni i odmah obavijestite svog liječnika.
English: A carcinogenicity study in rats is ongoing.
Croatian: Ispitivanje kancerogenosti na štakorima je u tijeku.
English: Patients with a CPT score > 12 were excluded.
Croatian: Pacijenti s rezultatom CPT > 12 bili su isključeni.
English: e. These are drugs within class where similar interactions could be predicted.
Croatian: Ovo su lijekovi iz iste klase za koje se mogu predvidjeti slične interakcije.
English: Number of responders at end of treatment
Croatian: Broj pacijenata s odgovorom na kraju liječenja
English: Of the 155 patients enrolled, 1 patient discontinued treatment whilst on placebo.
Croatian: Od 155 uključenih pacijenata, 1 je pacijent prekinuo liječenje dok je uzimao placebo.
English: Cimetidine e
Croatian: Cimetidin e
English: Race: Black/ African American
Croatian: Rasa: Crnci/ Afroamerikanci
English: This includes herbal medicines and medicines obtained without a prescription.
Croatian: To uključuje biljne pripravke i lijekove koji se mogu nabaviti bez recepta.
English: h. Bioequivalence/Equivalence boundary 80-125%.
Croatian: h. Granica bioekvivalencija/ekvivalencije od 80 % do 125 %.
English: * Includes patients co-infected with human immunodeficiency virus (HIV).
Croatian: * Uključuje pacijente istovremeno zaražene virusom humane imunodeficijencije (HIV).
English: Famotidine dosed 12 hours prior to Harvonid
Croatian: Famotidin primijenjen 12 sati prije lijeka Harvonid
English: Patients in these studies had compensated liver disease.
Croatian: Pacijenti u tim ispitivanjima imali su kompenziranu bolest jetre.
English: Ribavirin was discontinued in 19% of the patients.
Croatian: Primjena ribavirina bila je obustavljena u 19 %
English: It is given to treat chronic (long-term) hepatitis C virus infection in adults of 18 years and older.
Croatian: Daje se za liječenje kronične (dugotrajne) infekcije virusom hepatitisa C u odraslih u dobi od 18 godina i starijih.
English: In clinical studies - Genotype 1
Croatian: U kliničkim ispitivanjima - genotip 1
English: Consequently, consideration should be given to longer treatment for patients with uncertain subsequent retreatment options.
Croatian: Zbog toga treba razmotriti dugotrajnije liječenje pacijenata u kojih daljnja mogućnost ponovnog liječenja nije sigurna.
English: Harvoni is not recommended for use in children and adolescents under 18 years of age because the safety and efficacy have not been established in this population.
Croatian: Harvoni se ne preporučuje za primjenu u djece i adolescenata u dobi do 18 godina zato što njegova sigurnost i djelotvornost nisu ustanovljene u ovoj populaciji.
English: • if you have a current or previous infection with the hepatitis B virus, since your doctor may want to monitor you more closely;
Croatian: • ako imate ili ste prethodno imali infekciju virusom hepatitisa B, jer će Vas liječnik možda htjeti pobliže pratiti;
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 17 November 2014
Croatian: Datum prvog odobrenja: 17. studenog 2014.
English: What you need to know before you take Harvoni
Croatian: Što morate znati prije nego počnete uzimati Harvoni
English: Treatment of overdose with Harvoni consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient.
Croatian: Liječenje predoziranja lijekom Harvoni sastoji se od općih potpornih mjera uključujući praćenje vitalnih znakova kao i promatranje kliničkog stanja pacijenta.
English: Such patients may therefore be dependent on other drug classes for clearance of HCV infection.
Croatian: Takvi pacijenti, stoga, mogu ovisiti o drugim klasama lijekova za uklanjanje infekcije HCV-om.
English: Patients should be instructed to swallow the tablet whole with or without food.
Croatian: Pacijentima treba savjetovati da tabletu progutaju cijelu s hranom ili bez nje.
English: c. Administered as Harvoni.
Croatian: c. Primijenjen kao Harvoni.
English: Pharmacotherapeutic group: Direct-acting antiviral, ATC code: J05AX65
Croatian: Farmakoterapijska skupina: antivirusni lijek s izravnim djelovanjem; ATK oznaka: J05AX65
English: CPT A = CPT score 5-6 (compensated), CPT B = CPT score 7-9 (decompensated), CPT C = CPT score 10-12 (decompensated).
Croatian: CPT A = CPT rezultat 5-6 (kompenzirani), CPT B = CPT rezultat 7-9 (dekompenzirani), CPT C = CPT rezultat 10-12 (dekompenzirani).
English: If overdose occurs the patient must be monitored for evidence of toxicity.
Croatian: U slučaju predoziranja, pacijent se mora nadzirati zbog znakova toksičnosti.
English: In order to evaluate the recurrence of hepatocellular carcinoma associated with Harvoni, the MAH shall conduct and submit the results of a prospective safety study using data deriving from a cohort of a well-defined group of patients, based on an agreed protocol.
Croatian: Kako bi se procijenilo ponovno pojavljivanje hepatocelularnog karcinoma povezanog s primjenom Harvoni, nositelj odobrenja mora provesti i dostaviti rezultate prospektivnog ispitivanja sigurnosti, koristeći podatake koji proizlaze iz kohorte dobro definirane skupine bolesnika, na temelju dogovorenog protokola.
English: g. This study was conducted in the presence of another two direct-acting antiviral agents.
Croatian: g. Ispitivanje je provedeno u prisutnosti druga dva antivirusna lijeka s izravnim djelovanjem.
English: Clinical studies of ledipasvir/sofosbuvir included 235 patients (8.6% of total number of patients) aged 65 years and over.
Croatian: Klinička ispitivanja ledipasvira/sofosbuvira uključila su 235 pacijenata (8,6 % od ukupnog broja pacijenata) u dobi od 65 i više godina.
English: Only patients who demonstrated SVR12 or relapse were included in relapse analyses.
Croatian: Samo su pacijenti koji su postigli SVR12 ili imali relaps bili uključeni u analizu relapsa.
English: No effect = 1.00. b. All interaction studies conducted in healthy volunteers.
Croatian: Sva ispitivanja interakcija provedena su u zdravih dobrovoljaca.
English: Rabeprazolee Pantoprazole e
Croatian: Rabeprazole Pantoprazol e
English: In genotype 4, 5 and 6 infection, only small numbers of patients have been evaluated (total of 5 patients with failure).
Croatian: Kod infekcije genotipom 4, 5 i 6, procijenjen je samo mali broj pacijenata (ukupno 5 pacijenata kod kojih je došlo do virološkog neuspjeha).
English: Treatment with Harvoni should be guided by an assessment of the potential benefits and risks for the individual patient.
Croatian: U liječenju lijekom Harvoni treba se oslanjati na procjenu mogućih koristi i rizika za pojedinog pacijenta.
English: Consequently, patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicinal product.
Croatian: Zbog toga pacijenti s rijetkim nasljednim poremećajima nepodnošenja galaktoze, pomanjkanja Lapp laktaze ili s malapsorpcijom glukoze-galaktoze ne smiju uzimati ovaj lijek.
English: Patients with decompensated cirrhosis, irrespective of transplant status
Croatian: Pacijenti s dekompenziranom cirozom, bez obzira na transplantacijski status
English: Sofosbuvir is approximately 61-65% bound to human plasma proteins and the binding is independent of drug concentration over the range of 1 μg/mL to 20 μg/mL.
Croatian: Sofosbuvir je približno 61-65 % vezan za proteine ljudske plazme i vezanje ne ovisi o koncentraciji lijeka u rasponu 1 μg/ml do 20 μg/ml.
English: Harvoni is indicated for the treatment of chronic hepatitis C (CHC) in adults (see sections 4.2, 4.4 and
Croatian: Harvoni je indiciran za liječenje kroničnog hepatitisa C (CHC) u odraslih (vidjeti dijelove 4.2, 4.4 i
English: Metavir score F0-F3 96% (53/55) CPT A
Croatian: Poslije transplantacije Metavir rezultat F0-F3 96 % (53/55) CPT A
English: Due to the long half-life of amiodarone, appropriate monitoring should also be carried out for patients who have discontinued amiodarone within the past few months and are to be initiated on Harvoni.
Croatian: Zbog dugog poluvijeka amiodarona, treba također provesti odgovarajuće nadziranje bolesnika koji su prekinuli uzimanje amiodarona unutar nekoliko posljednjih mjeseci, a započet će terapiju s lijekom
English: Clinical and biochemical control is recommended in these patients and a dose adjustment may be needed (see section 4.4).
Croatian: U ovih se pacijenata preporučuje klinička i biokemijska kontrola i može biti potrebna prilagodba doze (vidjeti dio 4.4).
English: PHARMACEUTICAL FORM AND CONTENTS 28 film-coated tablets.
Croatian: OBLIK I SADRŽAJ 28 filmom obloženih tableta.
English: A coagulation test helps to identify patients with an increased bleeding risk due to increased dabigatran exposure.
Croatian: Pomoću testova koagulacije mogu se prepoznati pacijenti s povećanim rizikom od krvarenja zbog povećane izloženosti dabigatranu.
English: • kidney problems, since Harvoni has not been fully tested in patients with severe kidney problems;
Croatian: • tegobe s bubrezima, budući da Harvoni nije u potpunosti ispitan u bolesnika s teškim tegobama s bubrezima;
English: If the starting dose is not well-tolerated, the dose should be reduced as clinically indicated based on haemoglobin levels.
Croatian: Ako se početna doza ne podnosi dobro, tu je dozu potrebno sniziti kako je klinički indicirano na temelju razina hemoglobina.
English: All 5 patients who did not achieve SVR12 relapsed after having end-of-treatment response (see section “Resistance” - “In clinical studies” above).
Croatian: Svih 5 pacijenata koji nisu postigli SVR12 imalo je relaps nakon terapijskog odgovora na kraju liječenja (vidjeti dio “Rezistencija” - “U kliničkim ispitivanjima”, gore).
English: Ledipasvir plasma exposure (AUCinf) was similar in patients with severe hepatic impairment and control patients with normal hepatic function.
Croatian: Izloženost ledipasviru u plazmi (AUCinf) bila je slična u pacijenata s teškim oštećenjem jetre i kontrolnih pacijenata s normalnom jetrenom funkcijom.
English: Table 2 provides guidelines for dose modifications and discontinuation based on the patient's haemoglobin concentration and cardiac status.
Croatian: Tablica 2 nudi smjernice za prilagodbu doze i prekid primjene na temelju koncentracije hemoglobina i srčanog statusa pacijenta.
English: Fifty-five percent (55%) of the patients were treatment-experienced.
Croatian: Prethodno je bilo liječeno 55 % pacijenata.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/14/958/001 28 film-coated tablets EU/1/14/958/002 84 (3 bottles of 28) film-coated tablets
Croatian: 12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/14/958/001 28 filmom obloženih tableta EU/1/14/958/002 84 (3 boce s 28) filmom obloženih tableta
English: Medicinal products that have a narrow therapeutic range and which are metabolised by these isoenzymes should be used with caution and carefully monitored.
Croatian: Lijekove s uskom terapijskom širinom koje metaboliziraju ovi izoenzimi treba primjenjivati s oprezom i pažljivo pratiti.
English: • Do not take any other medicine that contains sofosbuvir, one of the active substances in Harvoni.
Croatian: • Nemojte uzimati nijedan drugi lijek koji sadrži sofosbuvir, što je jedna od djelatnih tvari u lijeku Harvoni.
English: INFORMATION IN BRAILLE Harvoni [Outer packaging only]
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Harvoni [samo vanjsko pakiranje]
English: d. Lack of pharmacokinetics interaction bounds 70-143%.
Croatian: Raspon u kojem nema farmakokinetičkih interakcija je od 70 % do 143 %. e.
English: Driving and using machines Do not drive or operate machines if you feel tired after taking your medicine.
Croatian: Nemojte upravljati vozilima ili strojevima ako osjećate umor nakon uzimanja lijeka.
English: That risk is even higher if ribavirin is used as part of the HCV treatment.
Croatian: Taj je rizik još i veći ako se, kao dio liječenja HCV-a,
English: As liver function may change during treatment with Harvoni, a close monitoring of International Normalised Ratio (INR) values is recommended.
Croatian: Budući da tijekom liječenja Harvoni može doći do promjene u funkciji jetre, preporučuje se pomno praćenje vrijednosti međunarodnog normaliziranog omjera (INR).
English: 10% of liver transplant recipients had a modification of their immunosuppressive agents.
Croatian: U 10 % pacijenata kojima je transplantirana jetra, primjena imunosupresivnih lijekova bila je modificirana.
English: These studies did not include any control group not receiving ledipasvir/sofosbuvir.
Croatian: U ta ispitivanja nisu bile uključene kontrolne skupine koje nisu primale ledipasvir/sofosbuvir.
English: Genotype 2, 3, 4, 5 and 6
Croatian: Genotip 2, 3, 4, 5 i 6
English: Harvoni treatment should be initiated and monitored by a physician experienced in the management of patients with CHC.
Croatian: Liječenje lijekom Harvoni treba započeti i nadzirati liječnik s iskustvom u liječenju pacijenata s CHC
English: • rosuvastatin (a medicine used to treat high cholesterol).
Croatian: • rosuvastatin (lijek koji se primjenjuje za liječenje visokog kolesterola).
English: Seven patient populations are being evaluated (patients with decompensated cirrhosis [CPT B and C] pre-transplant; post-transplant, no cirrhosis; post-transplant CPT A; post-transplant CPT B; post-transplant CPT C; post-transplant fibrosing cholestatic hepatitis [FCH]).
Croatian: Procjenjuje se sedam populacija pacijenata (pacijenti s dekompenziranom cirozom [CPT B i C] prije transplantacije; poslije transplantacije, bez ciroze; poslije transplantacije, CPT A; poslije transplantacije CPT B; poslije transplantacije CPT C; poslije transplantacije fibrozirajući kolestatski hepatitis [FKH]).
English: Lansoprazole e
Croatian: Lansoprazol e